metformin has been researched along with sulfamerazine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Huttunen, KM; Järvinen, T; Kemppainen, E; Laine, K; Leppänen, J; Mannila, A; Rautio, J; Vepsäläinen, J | 1 |
Huttunen, KM; Laine, K; Leppänen, J; Rautio, J; Vepsäläinen, J | 1 |
Huttunen, KM; Peura, L | 1 |
Huttunen, KM; Markowicz-Piasecka, M; Mikiciuk-Olasik, E; Sikora, J | 1 |
Huttunen, KM; Markowicz-Piasecka, M; Mateusiak, Ł; Mikiciuk-Olasik, E; Sikora, J | 1 |
Broncel, M; Huttunen, KM; Markowicz-Piasecka, M; Sikora, J | 1 |
8 other study(ies) available for metformin and sulfamerazine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
The first bioreversible prodrug of metformin with improved lipophilicity and enhanced intestinal absorption.
Topics: Animals; Biological Availability; Buffers; Drug Design; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Male; Metformin; Octanols; Prodrugs; Rats; Rats, Wistar; Solutions; Sulfamerazine; Water | 2009 |
Convenient microwave-assisted synthesis of lipophilic sulfenamide prodrugs of metformin.
Topics: Animals; Caco-2 Cells; Chemistry, Pharmaceutical; Cysteine; Glutathione; Humans; Hypoglycemic Agents; Metformin; Microwaves; Permeability; Prodrugs; Rats; Sulfamerazine | 2013 |
Sustained release of metformin via red blood cell accumulated sulfenamide prodrug.
Topics: Administration, Oral; Animals; Delayed-Action Preparations; Dose-Response Relationship, Drug; Erythrocytes; Half-Life; Hypoglycemic Agents; Injections, Intravenous; Metformin; Prodrugs; Rats; Sulfamerazine; Time Factors | 2014 |
Biocompatible sulfenamide and sulfonamide derivatives of metformin can exert beneficial effects on plasma haemostasis.
Topics: Biocompatible Materials; Drug Stability; Erythrocytes; Fibrinolysis; Hemolysis; Metformin; Microscopy, Phase-Contrast; Partial Thromboplastin Time; Prothrombin Time; Sulfamerazine; Sulfanilamide; Sulfanilamides | 2018 |
Sulfenamide and sulfonamide derivatives of metformin can exert anticoagulant and profibrinolytic properties.
Topics: Anticoagulants; Antithrombin III; Blood Coagulation; Diabetes Mellitus, Type 2; Factor X; Fibrinolysis; Humans; Metformin; Protein C; Sulfamerazine; Sulfonamides; Thrombin Time | 2018 |
Sulfenamide and Sulfonamide Derivatives of Metformin - A New Option to Improve Endothelial Function and Plasma Haemostasis.
Topics: Diabetes Mellitus, Type 2; Human Umbilical Vein Endothelial Cells; Humans; Metformin; Myocytes, Smooth Muscle; Sulfamerazine; Sulfonamides; Thromboplastin; von Willebrand Factor | 2019 |